logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
A

Amer M. Zeidan

Yale University

56H指数
842论文数
1.2W被引数
收录论文 186
发表时间
logo
The PRIME trial: An investigator-initiated, multicentre, phase II study of the poly(ADP-ribose) polymerase inhibitor olaparib in isocitrate dehydrogenase (IDH)-mutated relapsed/refractory acute myeloid leukaemia and myelodysplastic syndromesPRIME试验：一项由研究者发起的多中心II期研究，评估聚(ADP-核糖)聚合酶抑制剂奥拉帕利在异柠檬酸脱氢酶(IDH)突变复发/难治性急性髓系白血病和骨髓增生异常综合征中的应用
errBritish Journal of Haematology
IF3.8
err2026-09-06
err0
errOAAI
errRory M. Shallis; Jennifer VanOudenhove; Namrata Chandhok; Justin Watts; Deepa Jeyakumar; Daniel R. Reed; Jan Phillip Bewersdorf; Diane Durecki; Scott Boerner; Richard F. Little; Steven D. Gore; Jing Li; Xun Bao; Li Chen; Sayak Ghatak; Thomas Prebet; Ranjit S. Bindra; Amer M. Zeidan; Stephanie Halene
err分享
err收藏
Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study
errLeukemia
IF13.4
err2026-08-31
err0
PREAI
errTalha Badar; James Foran; Omer Jamy; Chenyu Lin; Anand Patel; Yu-Hung Wang; Mahesh Kumar; Rory M. Shallis; Kendall Diebold; Alexander Coltoff; Aaron D. Goldberg; Jan P. Bewersdorf; Kenneth M. Zabel; Charles Foucar; Yasmin Abaza; Guru S. Murthy; Neil Palmisiano; Adam S. DuVall; Vamsi Kota; Shyam A. Patel; Amer M. Zeidan; Hemant Murthy; Mohamed Kharfan-Dabaja; Ehab Atallah; Mark R. Litzow
err分享
err收藏
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS)基于低甲基化制剂治疗的反应对高风险骨髓增生异常综合征/肿瘤患者生存结局的影响：考虑基线临床-分子风险和移植状态的国际骨髓增生异常综合征联盟(icMDS)分析
errAmerican Journal of Hematology
IF9.9
err2026-08-28
err0
PREAI
errBenjamin Rolles; Jan Philipp Bewersdorf; Tariq Kewan; Ondrej Blaha; Jessica M. Stempel; Luca Lanino; Najla H. Al Ali; Amy E. DeZern; Mikkael A. Sekeres; Geoffrey L. Uy; Samuel Urrutia; Hetty E. Carraway; Pinkal Desai; Elizabeth A. Griffiths; Eytan M. Stein; Andrew M. Brunner; Christine McMahon; Rory M. Shallis; Joshua F. Zeidner; Michael R. Savona; Shougat Barua; Namrata Sonia Chandhok; Constantine Logothetis; Aram Bidikian; Ted M. Getz; Gail J. Roboz; Eunice S. Wang; Amyah C. Harris; Maria L. Amaya; Hayley Hawkins; Somedeb Ball; Justin Grenet; Parisa Abedi; Shai Shimony; R. Coleman Lindsley; Zhuoer Xie; Yazan F. Madanat; Yasmin Abaza; Talha Badar; Torsten Haferlach; Jaroslaw P. Maciejewski; David Sallman; Anoop Enjeti; Kamal Al-Rabi; Khalid Halahleh; Devendra Hiwase; Maria Diez-Campelo; David Valcarcel; Claudia Haferlach; Lisa Pleyer; Ioannis Kotsianidis; Vasiliki Pappa; Valeria Santini; Angela Consagra; Aref Al-Kali; Seishi Ogawa; Yasuhito Nannya; Matteo Giovanni Della Porta; Rami S. Komrokji; Amer M. Zeidan; Maximilian Stahl
err分享
err收藏
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax—an analysis from the International Consortium for MDS (icMDS) VALIDATE database高风险骨髓增生异常综合征/新生物患者接受去甲基化药物+维奈克拉治疗后的结局分析——国际骨髓增生异常综合征（icMDS）VALIDATE数据库分析
errBlood Cancer Journal
IF11.6
err2026-06-29
err0
errOAAI
errJan Philipp Bewersdorf; Tariq Kewan; Luca Lanino; Wei Wei; Tulika Rudra Gupta; Jessica M. Stempel; Najla H. Al Ali; Amy E. DeZern; Mikkael A. Sekeres; Geoffrey L. Uy; Samuel Urrutia; Hetty E. Carraway; Pinkal Desai; Elizabeth A. Griffiths; Eytan M. Stein; Andrew M. Brunner; Christine McMahon; Rory M. Shallis; Joshua F. Zeidner; Michael R. Savona; Hayley Hawkins; Namrata Sonia Chandhok; Constantine N. Logothetis; Aram Bidikian; Ted M. Getz; Gail J. Roboz; Benjamin Rolles; Eunice S. Wang; Amyah C. Harris; Maria L. Amaya; Somedeb Ball; Justin Grenet; Zhuoer Xie; Yazan F. Madanat; Yasmin Abaza; Talha Badar; Jaclynn Campos; Torsten Haferlach; Jaroslaw P. Maciejewski; David Sallman; Anoop Enjeti; Kamal Al-Rabi; Khalid Halahleh; Devendra Hiwase; Maria Diez-Campelo; David Valcarcel; Claudia Haferlach; Lisa Pleyer; Ioannis Kotsianidis; Vassiliki Pappa; Valeria Santini; Angela Consagra; Aref Al-Kali; Seishi Ogawa; Yasuhito Nannya; Maximilian Stahl; Matteo Giovanni Della Porta; Rami S. Komrokji; Amer M. Zeidan
err分享
err收藏
Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution基于分子演化的骨髓增生异常综合征预后评分
errNEJM Evidence
IF0
err2026-05-26
err2
PREAI
errCivettini, Ivan; Malighetti, Federica; Villa, Matteo; Crippa, Valentina; Aroldi, Andrea; Cavalca, Fabrizio; Graudenzi, Alex; Lanino, Luca; Maggioni, Giulia; Haferlach, Torsten; Fenaux, Pierre; Platzbecker, Uwe; Diez-Campelo, Maria; Borin, Lorenza Maria; Fumagalli, Monica; Zappaterra, Arianna; Manghisi, Beatrice; Al Ali, Najla H.; Sallman, David A.; Padron, Eric; Xie, Zhuoer; Chan, Onyee; Zeidan, Amer M.; Mologni, Luca; Piazza, Rocco; Komrokji, Rami S.; Della Porta, Matteo Giovanni; Gambacorti-Passerini, Carlo; Ramazzotti, Daniele
err分享
err收藏
Clinical strategies for leukemia management: Recommendations from the Bridging the Gaps in Hematology Oncology Consensus Conference 2025白血病管理临床策略：2025年血液肿瘤学弥合差距共识会议的建议
errLeukemia Research
IF2.2
err2026-05-01
err0
PREAI
errCarraway, Hetty E.; Deangelo, Daniel J.; Wang, Eunice S.; Komrokji, Rami S.; Perl, Alexander E.; Zeidan, Amer; Brunner, Andrew; Lai, Catherine; Park, Jae H.; Zeidner, Joshua F.; Weeks, Lachelle; Luskin, Marlise R.; Chandhok, Namrata S.; Loghavi, Sanam
err分享
err收藏
Targeting metabolism in acute myeloid leukemia: the next therapeutic frontier?靶向急性髓系白血病的代谢：下一个治疗前沿？
errChinese Clinical Oncology
IF2.5
err2026-04-30
err0
PREAI
errMina, Alain; Zeidan, Amer M.
err分享
err收藏
Acute myeloid leukemia after myeloproliferative neoplasms: Real-world outcomes in the new treatment era in the United States骨髓增殖性肿瘤后的急性髓系白血病：美国新治疗时代的真实世界结果
errCancer
IF5.1
err2026-04-25
err0
PREAI
errJan Philipp Bewersdorf MD; Rong Wang PhD; Lourdes Mendez MD, PhD; Alain Mina MD; Luis E. Aguirre MD; Maximilian Stahl MD; Amer M. Zeidan MBBS, MHS; Xiaomei Ma PhD; Nikolai A. Podoltsev MD, PhD
err分享
err收藏
A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions2026年骨髓增生异常肿瘤的最新进展：当前状态、挑战与未来方向
errNature Reviews Clinical Oncology
IF82.2
err2026-04-14
err0
PREAI
errJan Philipp Bewersdorf; Alain Mina; Maximilian Stahl; Amer M. Zeidan
err分享
err收藏
Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes治疗相关细胞减少症与低危骨髓增生异常综合征患者对imetelstat临床反应之间的关联
errBlood Cancer Journal
IF11.6
err2026-04-07
err0
errOAAI
errAmer M. Zeidan; Valeria Santini; María Díez-Campelo; Michael R. Savona; Mikkael A. Sekeres; Yazan F. Madanat; Pierre Fenaux; Azra Raza; Moshe Mittelman; Sylvain Thépot; Rena Buckstein; Ulrich Germing; David Valcárcel; Anna Jonášová; Sheetal Shah; Qi Xia; Libo Sun; Shyamala Navada; Tymara Berry; Uwe Platzbecker; Rami S. Komrokji
err分享
err收藏
Real-world study of use patterns and clinical outcomes for patients with myelodysplastic syndrome initiating oral decitabine and cedazuridine or intravenous/subcutaneous hypomethylating agents
errTherapeutic Advances in Hematology
IF3.1
err2026-02-17
err0
errOAAI
errAmer M. Zeidan; Ruizhi Zhao; Jon G. Tepsick; Ziyu Lan; Tehseen Salimi
err分享
err收藏
Isavuconazole provides effective and tolerable antifungal prophylaxis for patients with acute myeloid leukemia伊沙库唑唑为急性髓系白血病患者提供了有效且耐受性良好的抗真菌预防。
errLEUKEMIA RESEARCH
IF2.2
err2025-12-01
err0
PREAI
errHunter, Cameron J.; Chou, Andrew; Roeder, Heidi; Eighmy, William; Bewersdorf, Jan Philipp; Mendez, Lourdes; Stahl, Maximilian; Podoltsev, Nikolai A.; Zeidan, Amer M.; Shallis, Rory M.
err分享
err收藏
Decitabine-cedazuridine in patients with MDS and TP53 mutations地西他滨-西达佐鲁定在伴TP53突变的患者中的研究
errBlood Advances
IF7.1
err2025-11-14
err0
errOAAI
errSamuel Urrutia; Koji Sasaki; Alex Bataller; Hagop Kantarjian; Guillermo Montalban-Bravo; James McCloskey; Elizabeth A. Griffiths; Karen Yee; Amer Zeidan; Michael Savona; Aram Oganesian; Yuri Sano; Harold N. Keer; Guillermo García-Manero
err分享
err收藏
The conundrum of drug development in higher-risk MDS: Lessons learned from recently failed phase 3 clinical trials高风险MDS药物开发的困境：从近期失败的III期临床试验中汲取的教训
errBlood
IF23.1
err2025-11-04
err0
PREAI
errMaximilian Stahl; Amer M. Zeidan
err分享
err收藏
Clinical outcomes and safety in patients with lower-risk myelodysplastic syndromes treated with imetelstat: Substudy of the phase 3 IMerge trial低危骨髓增生异常综合征患者接受伊米替列stat治疗后的临床疗效与安全性：IMerge三期试验的子研究
errBRITISH JOURNAL OF HAEMATOLOGY
IF3.8
err2025-11-01
err0
errOAAI
errKomrokji, Rami S.; Santini, Valeria; Platzbecker, Uwe; Van Eygen, Koen; Diez-campelo, Maria; De Paz, Raquel; Santillana, Guillermo Sanz; Thepot, Sylvain; Kazmierczak, Maciej; Oliva, Esther Natalie; Sekeres, Mikkael A.; Fenaux, Pierre; Madanat, Yazan F.; Savona, Michael R.; Riggs, Jennifer; Shah, Sheetal; Lennox, Ashley L.; Xia, Qi; Sun, Libo; Berry, Tymara; Zeidan, Amer M.
err分享
err收藏
Artificial intelligence in myeloid malignancies: Clinical applications of machine learning in myelodysplastic syndromes and acute myeloid Leukemia人工智能在髓系恶性肿瘤中的应用：机器学习在骨髓增生异常综合征和急性髓系白血病中的临床应用
errBlood Reviews
IF5.7
err2025-10-16
err0
PREAI
errJowan Al-Nusair; Luca Lanino; Arda Durmaz; Matteo Giovanni Della Porta; Amer M. Zeidan; Tariq Kewan
err分享
err收藏
Outcomes of older patients with TP53-mutated myeloid neoplasmsTP53突变髓系肿瘤老年患者的结局
errBlood Cancer Journal
IF11.6
err2025-10-07
err0
errOAAI
errOmer Jamy; Mobachir El Kettani; Kashish Shah; Rory M. Shallis; Kendall Diebold; Alexander Coltoff; Aaron D. Goldberg; Anand Patel; Jan P. Bewersdorf; Charles Foucar; Yasmin Abaza; Neil Palmisiano; Adam S. DuVall; Vamsi Kota; Shyam A. Patel; Amer M. Zeidan; Ehab Atallah; Mark R. Litzow; Talha Badar
err分享
err收藏
Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/Neoplasms国际骨髓增生异常综合征/骨髓肿瘤工作组关于骨髓报告标准化的共识
errARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
IF3.2
err2025-10-01
err0
errOAAI
errGisriel, Savanah D.; Aakash, Fnu; Bennett, John M.; Hasserjian, Robert P.; Loghavi, Sanam; Dezern, Amy E.; Santini, Valeria; Savona, Michael R.; Brunner, Andrew M.; Buckstein, Rena; Wei, Andrew H.; Della Porta, Matteo G.; Komrokji, Rami S.; Borate, Uma M.; Sekeres, Mikkael A.; Platzbecker, Uwe; Fenaux, Pierre; Roboz, Gail J.; van de Loosdrecht, Arjan; Zeidan, Amer M.; Xu, Mina L.
err分享
err收藏
Luspatercept for Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms: A Systematic Review and Meta-Analysis.Luspatercept在低风险骨髓增生异常综合征/肿瘤患者中的应用：一项系统评价和Meta分析。
errBlood Advances
IF7.1
err2025-09-23
err0
errOAAI
errAbdulrahman Alhajahjeh; Naira Woite; Benjamin Rolles; Jessica M. Stempel; Alain Mina; Lourdes Mendez; Tariq Kewan; Nikolai A. Podoltsev; Maximilian Stahl; Alyssa A. Grimshaw; Amer M. Zeidan; Jan Philipp Bewersdorf
err分享
err收藏
IMPACT OF PRIOR TREATMENTS ON THE CLINICAL ACTIVITY OF IMETELSTAT IN PATIENTS WITH TRANFUSION-DEPENDENT (TD), ERYTHROPOIESIS-STIMULATING AGENT (ESA) RELAPSED/REFRACTORY/INELIGIBLE LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS)既往治疗对输血依赖性（TD）、促红细胞生成剂（ESA）复发/难治/不适用低危骨髓增生异常综合征（LR-MDS）患者中imetelstat临床活性的影响
errLEUKEMIA RESEARCH
IF2.2
err2025-09-01
err0
errOAAI
errPlatzbecker, Uwe; Santini, Valeria; Zeidan, Amer; Sekeres, Mikkael; Fenaux, Pierre; Raza, Azra; Mittelman, Moshe; Thepot, Sylvain; Buckstein, Rena; Germing, Ulrich; Madanat, Yazan; Diez-Campelo, Maria; Ferreiras, David Valcarcel; Jonasova, Anna; Dougherty, Souria; Shah, Sheetal; Xia, Qi; Sun, Libo; Navada, Shyamala; Savona, Michael; Komrokji, Rami
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
H
Hagop M. Kantarjian
H 指数: 230 · 论文数: 5.5K
J
Jörge E. Cortes
H 指数: 179 · 论文数: 3.6K
V
Vijay K. Kuchroo
H 指数: 157 · 论文数: 682
D
Donna Neuberg
H 指数: 155 · 论文数: 1.7K
G
Guillermo Garcia‐Manero
H 指数: 149 · 论文数: 2.9K
查看更多